General Information of Drug (ID: DMAAHOF)

Drug Name
Anti-SARS-CoV-2 REGN-COV2 vaccine
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D0H1WT

References

1 Regeneron begins first clinical trials of anti-viral antibody cocktail regn-cov2 for the treatment and prevention of COVID-19. June 11, 2020.